Details
Stereochemistry | RACEMIC |
Molecular Formula | C8H19N |
Molecular Weight | 129.2432 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)CCCC(C)N
InChI
InChIKey=QNIVIMYXGGFTAK-UHFFFAOYSA-N
InChI=1S/C8H19N/c1-7(2)5-4-6-8(3)9/h7-8H,4-6,9H2,1-3H3
Molecular Formula | C8H19N |
Molecular Weight | 129.2432 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/29115866Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/6891293 | https://www.ncbi.nlm.nih.gov/pubmed/14881080
Sources: https://www.ncbi.nlm.nih.gov/pubmed/29115866
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/6891293 | https://www.ncbi.nlm.nih.gov/pubmed/14881080
Octodrine is a stimulant that is structurally similar to amphetamine and is included in several so-called “pre-workout” and “fat-burning” supplements. Octodrine, has a history of use as a pharmaceutical drug. It was originally developed in the United States as an aerosolized treatment for bronchitis, laryngitis and other conditions Initially approved by the FDA in 1946 as Eskay’s Oralator, this inhaler appeared only in the 1949 edition of the Physicians’ Desk Reference. Octodrine was combined with several other medications, including theophylline, 3-octopamine, and adenosine, in multi-ingredient tablets sold between the early 1960s through the mid-2000s under the trade names Ambredin, Ordinal, Ordinal Retard and Ordinal Forte. Some proponents say octodrine is a safer alternative to other stimulants like ephedra and Dimethylamylamine (DMAA), but there is no scientific information to support this claim. Originally developed in the early 1950’s as a remedy to nasal congestion and as a possible anti-tumor drug, Octodrine has resurfaced as a key ingredient in dietary supplements for its stimulant and thermogenic benefits.
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6891293 |
Primary | Unknown Approved UseUnknown |
||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/29115866
Maximum daily intake 8.5 g
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:00:36 GMT 2023
by
admin
on
Fri Dec 15 16:00:36 GMT 2023
|
Record UNII |
3GQ9E911BI
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29709
Created by
admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
|
||
|
DSLD |
3406 (Number of products:13)
Created by
admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB09414MIG
Created by
admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
|
PRIMARY | |||
|
2474
Created by
admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
|
PRIMARY | |||
|
C74107
Created by
admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
|
PRIMARY | |||
|
208-851-1
Created by
admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105833
Created by
admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
|
PRIMARY | |||
|
236867
Created by
admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
|
PRIMARY | RxNorm | ||
|
Octodrine
Created by
admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
|
PRIMARY | |||
|
759813
Created by
admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
|
PRIMARY | |||
|
10982
Created by
admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
|
PRIMARY | |||
|
1978
Created by
admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
|
PRIMARY | |||
|
3GQ9E911BI
Created by
admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
|
PRIMARY | |||
|
m8116
Created by
admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID8046535
Created by
admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
|
PRIMARY | |||
|
100000083866
Created by
admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
|
PRIMARY | |||
|
543-82-8
Created by
admin on Fri Dec 15 16:00:36 GMT 2023 , Edited by admin on Fri Dec 15 16:00:36 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
a very strong psychoactive central nervous system based stimulant. Its first use was to treat nasal congestion, but for many years now it has gained traction and popularity by popping up and being used in different preworkout and fat burning products. Little clinical study.
|